The current valuation score of Sonoma Pharmaceuticals Inc is 9.50, ranking 17 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is -0.59, which is -83.94% below the recent high of -0.10 and -430.25% above the recent low of -3.14.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.